158 related articles for article (PubMed ID: 28850793)
1. Medication adherence and improved outcomes among patients with type 2 diabetes.
Curtis SE; Boye KS; Lage MJ; Garcia-Perez LE
Am J Manag Care; 2017 Jul; 23(7):e208-e214. PubMed ID: 28850793
[TBL] [Abstract][Full Text] [Related]
2. The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US.
Hepp Z; Lage MJ; Espaillat R; Gossain VV
J Med Econ; 2018 Sep; 21(9):912-919. PubMed ID: 29865926
[TBL] [Abstract][Full Text] [Related]
3. Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
Pelletier EM; Pawaskar M; Smith PJ; Best JH; Chapman RH
J Med Econ; 2012; 15(6):1039-50. PubMed ID: 22533526
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database.
Eby EL; Bajpai S; Faries DE; Haynes VS; Lage MJ
J Manag Care Spec Pharm; 2020 Sep; 26(9):1081-1089. PubMed ID: 32857656
[TBL] [Abstract][Full Text] [Related]
5. The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018.
McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
J Manag Care Spec Pharm; 2022 May; 28(5):494-506. PubMed ID: 35392659
[No Abstract] [Full Text] [Related]
6. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
8. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program.
Pednekar P; Heller DA; Peterson AM
J Manag Care Spec Pharm; 2020 Sep; 26(9):1099-1108. PubMed ID: 32857648
[TBL] [Abstract][Full Text] [Related]
9. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
[TBL] [Abstract][Full Text] [Related]
10. Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis.
Eby EL; Wang P; Curtis BH; Xie J; Haldane DC; Idris I; Peters AL; Hood RC; Jackson JA
J Med Econ; 2013; 16(4):529-38. PubMed ID: 23363330
[TBL] [Abstract][Full Text] [Related]
11. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study.
Buysman EK; Liu F; Hammer M; Langer J
Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470
[TBL] [Abstract][Full Text] [Related]
12. Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database.
Boye KS; Curtis SE; Lage MJ; Garcia-Perez LE
Patient Prefer Adherence; 2016; 10():1573-81. PubMed ID: 27574406
[TBL] [Abstract][Full Text] [Related]
13. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization.
Sun P; Lian J
Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064
[TBL] [Abstract][Full Text] [Related]
14. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.
Mitra D; Hodgkins P; Yen L; Davis KL; Cohen RD
BMC Gastroenterol; 2012 Sep; 12():132. PubMed ID: 23006789
[TBL] [Abstract][Full Text] [Related]
15. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
[TBL] [Abstract][Full Text] [Related]
16. Does medication adherence lead to lower healthcare expenses for patients with diabetes?
Cheng SH; Chen CC; Tseng CH
Am J Manag Care; 2013 Aug; 19(8):662-70. PubMed ID: 24304214
[TBL] [Abstract][Full Text] [Related]
17. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
[TBL] [Abstract][Full Text] [Related]
18. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
19. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
Offord S; Lin J; Mirski D; Wong B
Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
[TBL] [Abstract][Full Text] [Related]
20. Insulin dosing and outcomes among commercially insured patients with type 2 diabetes in the United States.
Eby EL; Van Brunt K; Brusko C; Curtis B; Lage MJ
Clin Ther; 2015 Oct; 37(10):2297-2308.e1. PubMed ID: 26341171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]